DRUG CONCENTRATION MONITORING - AN APPROACH TO RATIONAL USE

被引:12
作者
BROWN, GR [1 ]
MIYATA, M [1 ]
MCCORMACK, JP [1 ]
机构
[1] UNIV BRITISH COLUMBIA,FAC PHARMACEUT SCI,VANCOUVER V6T 1W5,BC,CANADA
关键词
D O I
10.2165/00003088-199324030-00001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug concentration monitoring should currently be considered only as a tool to supplement clinical assessment of patient response. Consideration of appropriate drug selection, dosage and clinical monitoring of response is the most crucial component of patient therapy. Confirmation is required of the benefits of drug concentration monitoring in influencing patient outcome. Similarly, further research into methods of measuring drug concentrations at receptor sites, and the correlation of such concentration with outcome, would be a valuable addition to clinical assessment in adjusting drug therapy to achieve desirable patient outcomes. Until such data are available, only selective use of drug concentration monitoring is warranted in the appropriate clinical care of patients and to prevent inappropriate use of healthcare resources. © 1993, Adis International Limited. All rights reserved.
引用
收藏
页码:187 / 194
页数:8
相关论文
共 8 条
[1]   PRACTICAL OPTIMIZATION OF ANTIARRHYTHMIC DRUG-THERAPY USING PHARMACOKINETIC PRINCIPLES [J].
BAUMAN, JL ;
SCHOEN, MD ;
HOON, TJ .
CLINICAL PHARMACOKINETICS, 1991, 20 (02) :151-166
[2]   INDIVIDUALIZING GENTAMICIN DOSAGE REGIMENS IN BURN PATIENTS WITH GRAM-NEGATIVE SEPTICEMIA - COST-BENEFIT-ANALYSIS [J].
BOOTMAN, JL ;
WERTHEIMER, AI ;
ZASKE, D ;
ROWLAND, C .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (03) :267-272
[3]   CLINICAL PHARMACOKINETICS OF VERAPAMIL, NIFEDIPINE AND DILTIAZEM [J].
ECHIZEN, H ;
EICHELBAUM, M .
CLINICAL PHARMACOKINETICS, 1986, 11 (06) :425-449
[4]   A CRITICAL REEVALUATION OF THE THERAPEUTIC RANGE OF AMINOGLYCOSIDES [J].
MCCORMACK, JP ;
JEWESSON, PJ .
CLINICAL INFECTIOUS DISEASES, 1992, 14 (01) :320-339
[6]   KINETICS OF DRUG EFFECTS IN MAN [J].
OOSTERHUIS, B ;
VANBOXTEL, CJ .
THERAPEUTIC DRUG MONITORING, 1988, 10 (02) :121-132
[7]   THERAPEUTIC DRUG-MONITORING [J].
SPECTOR, R ;
PARK, GD ;
JOHNSON, GF ;
VESELL, ES .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (04) :345-353
[8]   THE VALUE OF THERAPEUTIC DRUG-MONITORING TO THE PRACTICING PHYSICIAN - AN HYPOTHESIS NEEDING SENSIBLE APPLICATION [J].
WATSON, ID ;
THOMSON, AH .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (05) :619-620